InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Perez Edith A., Directeur Médical. Officer active across 1 companies, notably Bolt Biotherapeutics, Inc.. Cumulatively, 2 disclosures have been published. Total volume traded: €25k. The latest transaction was disclosed on 4 June 2021 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Declarations2 total
€12,584917 shares@ €13.7229100.0% of flow
Common Stock
SEC:0000899243-22-003917·
Ideal exit: 1 Mar 2022 (T+270)
€12,584917 shares@ €13.72290.12% mcap50.0% of flow
Common Stock
SEC:0000899243-22-003917:0·
Ideal exit: 1 Mar 2022 (T+270)
2 of 2 declarations
About Perez Edith A.
Edith A. Perez is the Chief Medical Officer of Bolt Biotherapeutics, Inc. She is responsible for the company's medical direction, overseeing research and development initiatives and ensuring compliance with regulatory standards. Edith plays a key role in developing innovative therapeutic solutions and improving patient outcomes.
